Europe Autoimmune Disease Diagnostics Market Size

Europe Autoimmune Disease Diagnostics Market Analysis

The Europe Autoimmune Disease Diagnostics Market size is estimated at USD 1.38 billion in 2024, and is expected to reach USD 1.82 billion by 2029, growing at a CAGR of 5.69% during the forecast period (2024-2029).

The major factors driving the market are the increasing prevalence, along with the rising public awareness, technological advancements, and improved laboratory automation.

European countries are being confronted with an increase in the occurrence of the most autoimmune immune disorders. The prevalence rate of multiple sclerosis in Europe is estimated at 83 out of 100,000. Moreover, multiple sclerosis is more common among women than men. In addition, two million people are affected by rheumatoid arthritis and nearly 2-3% of the population is estimated to be affected by psoriasis, which is one of the most common forms of autoimmune diseases. Owing to the aforementioned conditions, early diagnosis and onset of treatment can make a significant difference in preventing permanent damage and disability. Results of autoimmune disease diagnostic tests can confirm a disorder, estimate disease severity, aid in assessing prognosis. They are also useful to follow disease activity.

The increasing awareness of auto-immune diseases, through programs of research, education, support, and advocacy is a key factor augmenting the usage rates. The European Commission is taking several steps to increase awareness among the public regarding the risk factors in developing autoimmune diseases. Thus, as symptoms occur, they can seek diagnosis and begin a treatment regimen.